Alk­er­mes touts equal ef­fi­ca­cy of month­ly Viv­it­rol against dai­ly Sub­ox­one

A new study com­par­ing two of the main drugs treat­ing opi­oid ad­dic­tion found that the med­i­cines worked sim­i­lar­ly in help­ing pa­tients quit hero­in and oth­er opi­oids.

That’s in­ter­est­ing news con­sid­er­ing the brand­ing bat­tle be­tween the two drug mak­ers, whose fierce (and some­times ug­ly) com­pe­ti­tion has drawn the at­ten­tion of politi­cians and re­porters at The New York Times.

The new study, pub­lished in The Lancet, com­pared In­di­v­ior’s drug Sub­ox­one with Alk­er­mes’ Viv­it­rol in an ex­per­i­ment with 570 adults.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER